Case File
efta-efta00651634DOJ Data Set 9OtherDS9 Document EFTA00651634
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00651634
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To:
Subject:
Attachments:
Eileen Alexanderson
"Jeffrey Epstein ([email protected])" <[email protected]>
FW: APO2 Trust
Fri, 25 Oct 2013 20:40:41 +0000
8 86490I-v5-
BLACK,LEON APO2 Trust_for_1997_Trust decanting_(NY,_AH„spouse as a_benefici
ary,_pot trust_an—d_cont;uing_trusts).doc; ATTZ0001..htm; Change-Pro_Redcine—_-
88649fil -v4-
TILACK,LEON APO2 Trust_for_1997 Trust decanting_(NY,AH,spouse_as_a_benefici
ary,_pot_trust_an—d_cont;uing_trusts)_anTdoc; ATT00002..htm
From: Ma Clapp Nab:,
Sent: Friday, October 25, 2013 4:39 PM
To: Eileen Alexanderson
Subject: Fwd: APO2 Trust
This is the kind of stuff that made it amateur hour.
Begin forwarded message:
From: "Jessica Soojian"
Subject: Fw: APO2 Trust
Date: October 22, 2013 8:36:25 PM EDT
To:
Cc: "Alan S Halperin"
Hi Ada—Apologies for the confusion. Please review these attached drafts, not what I sent at 7:51 (please ignore). Alan and
I discussed, and decided that we could include the exoneration provision since it fell within the confines of 10-6.6. Thanks
very much.
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained in
this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose
of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party
any transaction or matter addressed herein.
Click Here for More Information
Jessica D. Soojian I Associate
Paul, Weiss. Rificind, Wharton & Garrison LLP
the Americas I
019-6064
Direct Phone)
(Direct Fax)
I WIAV
Forwarded by Jessica Soojian/PaulWeiss on 10/22/2013 08:32 PM --
From:
Jessica Soojian/PaulWeiss
EFTA00651634
To:
Cc:
Alan S Hatpenn/PautWeiss@PaulWeiss
10122/2013 07:51 PM
Subject:
APO2 Trust
Hi Ada—I am attaching another revised draft of the APO2 Trust which incorporates one mare revision. Specifically, in
preparing the decanting documents for the 1997 Trust, it occurred to me that, in light of the Trust's silence with regard to
liability/exoneration, any inclusion of this language in the APO2 Trust would violate 10-6.6. Accordingly, the relevant
Clause has been removed.
Thanks very much,
Jess
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained in
this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose
of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party
any transaction or matter addressed herein.
Click Here for More Information
Jessica D. Soojian I Associate
Paul, Weiss, Rifkind, Wharton 8. Garrison LLP
the Americas I
19-6064
(Direct Phone)
irect Fax)
This message is intended only for the use of the Addressee and may contain information
that is privileged and confidential. If you are not the intended recipient, you are
hereby notified that any dissemination of this communication is strictly prohibited. If
you have received this communication in error, please erase all copies of the message and
its attachments and notify us immediately.
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged
material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
information by persons or entities other than the intended
recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
EFTA00651635
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.